After announcing this year’s Fierce 15 winners, we invited their executives to the Drug Development Forum in Boston to discuss some of the pivotal moments leading up to their win.
As the pharma and biotech industry rolls to the end of another quarter, some investors are keen to pick up information about possible stock surges due to positive pipelines, favorable regulatory news and the overall economic health of the country.